Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers

62Citations
Citations of this article
298Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Extrachromosomal DNA (ecDNA) amplification promotes intratumoral genetic heterogeneity and accelerated tumor evolution1–3; however, its frequency and clinical impact are unclear. Using computational analysis of whole-genome sequencing data from 3,212 cancer patients, we show that ecDNA amplification frequently occurs in most cancer types but not in blood or normal tissue. Oncogenes were highly enriched on amplified ecDNA, and the most common recurrent oncogene amplifications arose on ecDNA. EcDNA amplifications resulted in higher levels of oncogene transcription compared to copy number-matched linear DNA, coupled with enhanced chromatin accessibility, and more frequently resulted in transcript fusions. Patients whose cancers carried ecDNA had significantly shorter survival, even when controlled for tissue type, than patients whose cancers were not driven by ecDNA-based oncogene amplification. The results presented here demonstrate that ecDNA-based oncogene amplification is common in cancer, is different from chromosomal amplification and drives poor outcome for patients across many cancer types.

Cite

CITATION STYLE

APA

Kim, H., Nguyen, N. P., Turner, K., Wu, S., Gujar, A. D., Luebeck, J., … Verhaak, R. G. W. (2020). Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nature Genetics, 52(9), 891–897. https://doi.org/10.1038/s41588-020-0678-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free